High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India

BACKGROUND: The information on seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among patients with inflammatory bowel disease (IBD) and its comparison to healthy controls is sparse. We compared the seroprevalence rates in patients with IBD and healthy control...

Descripción completa

Detalles Bibliográficos
Autores principales: Kante, Bhaskar, Vuyyuru, Sudheer Kumar, Gupta, Ritu, Dwivedi, Tanima, Kumar, Peeyush, Mundhra, Sandeep, Golla, Rithvik, Virmani, Shubi, Verma, Mahak, Makharia, Govind, Ahuja, Vineet, Kedia, Saurabh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898695/
https://www.ncbi.nlm.nih.gov/pubmed/36738383
http://dx.doi.org/10.1007/s12664-022-01310-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898695/
https://www.ncbi.nlm.nih.gov/pubmed/36738383
http://dx.doi.org/10.1007/s12664-022-01310-y

Ejemplares similares